Certara Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Princeton NJ United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2021
NCT04846036
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Certara

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: Certara (0) Acquired (2)

azithromycin (zithromax) (1 trial)

heparin (liquaemin) (1 trial)

Drugs in Phase 2 Trials (3)

Key: Certara (1) Acquired (2)

eplerenone (inspra) (1 trial)

kh176 (2 trials)

osilodrostat (Isturisa) (2 trials)

Drugs in Phase 1 Trials (2)

Key: Certara (0) Acquired (2)

dasatinib (sprycel) (1 trial)

etc-1907206 (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 7